Enzo Biochem's Clinical Lab Acquires Marketing Rights To Unique, More Effective Diagnostic Test For Cervical Cancer
Links shared publicly online about this topic.
- 222total visits
Enzo Biochem's Clinical Lab Acquires Marketing Rights To Unique, More Effective Diagnostic Test For Cervical Cancer
Enzo Biochem Inc. (NYSE:ENZ), as part of its continuing program to offer novel molecular tests, announced that its Enzo Clinical Labs subsidiary has reached an agreement with IncellDx Inc. of Menl
View full resource at medicalnewstoday.com
Tags: HPV, Cancer, Cervical Cancer, Science
Most Recently Shared on June 14, 2011 at 1:03 am By:
Enzo Biochem's Clinical Lab Acquires Marketing Rights To Unique, More Effective Diagnostic Test For Cervical Can... http://bit.ly/iNghNr
Also Shared By:
Advertisement
MNT Cervical Cancer
@mnt_cervical
Enzo Biochem's Clinical Lab Acquires Marketing Rights To Unique, More Effective Diagnostic Test For Cervical Cancer http://mnt.to/3X6c
1 year ago...